Invests in publicly traded companies globally, with a specific focus on the science and technology sectors. Now — the numbers.
This is an established company with proven profits.
Average growth of 15% a year over the last 3 years. Red columns mark years that ended in a loss.
The market pays 6.7× for every dollar of annual profit — cheap, which is either an opportunity or a warning.
No analyst target is on record for this company.
Buys and sells are dead even — no clear signal either way.
The stock trades 29% below its peak. The market has trimmed its expectations for the company.
Over the last 4 years, sales grew about 15% a year on average.
It pays out $2.71 per share each year — regular cash for whoever holds the stock.
Our checks did not surface a specific risk to flag here. That is not the same as there being none.
We grade companies — revenue, margins, balance sheets. This is a fund, so there is no report card to give. That is not a low grade; it is a different kind of thing.
One-line summary: a basket, not a business. Judge it by what it holds.